propyliodone

Trade name: Dionosil

Small moleculeapproved

Approved

Jul 1, 1939

Propyliodone (INN, trade name Dionosil) is a molecule used as a contrast medium. It was developed by a team at Imperial Chemical Industries in the late 1930s. Propyliodone used as radiopque medium for brochographic use. When directly instilled into the bronchi resulting in well-defined bronchograms for atleast 30 min. Because of its toxicity, Propyliodone should only be used if absolutely essential. It is of Synthetic origin and belongs to Iodinated Radio-opaque Compounds. It belongs to Radiopaque Agents pharmacological group on the basis of mechanism of action and also classified in Diagnostic Aids pharmacological group. Oral absorption of Propyliodone is found to be 101% and metabolism is reported Lungs and Gut wall. Propyliodone is primarily indicated in conditions like Paget's disease of bone, Radiological contrast agent. Propyliodone produces potentially life-threatening effects which include Fever, Anaphylaxis, Repiratory obstruction, Cerebral embolization, which are responsible for the discontinuation of Propyliodone therapy. The signs and symptoms that are produced after the acute overdosage of Propyliodone include Airway obstruction. The symptomatic adverse reactions produced by Propyliodone are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Fever, Malaise, Nausea and vomiting, Aching joints. — NCATS

Clinical trial activity

0 trials · 0 clinical orgs · 1 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Timeline

1930s

  1. Jul 1, 1939

    Earliest FDA Approval

1980s

  1. Jun 6, 1986

    GlaxoSmithKline — First NDA Organization

  2. Jun 6, 1986

    GlaxoSmithKline — NDA Secondary Org

  3. Jun 6, 1986

    GlaxoSmithKline — NDA Organization

Indications

Mechanism of action

Approval history

  • approvedJul 1, 1939

Chemistry & pharmacology

Loading structure…

SMILES

CCCOC(=O)CN1C=C(I)C(=O)C(I)=C1
Mol. weight
447.0082 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No
Delivery
Parenteral
Availability
Discontinued

Oral

No

Parenteral

Yes

Topical

No

Sources

Also known as

  • dionosil
  • dionosil
  • dionosil
  • dionosil
  • dionosil aqueous
  • dionosil aqueous
  • dionosil oily
  • dionosil oily
  • propiodone
  • propyliodon
  • propyliodone
  • propyliodone
  • propyliodone
  • propyliodone
  • propyliodone
  • propyliodone
  • propyliodone
  • propyliodone

Organizations

Marketing (2)

OrganizationOrg typeRelationshipDate
GlaxoSmithKlineFor profitNDA2Jun 6, 1986
GlaxoSmithKlineFor profitNDAJun 6, 1986